Home › Diffuse Large B-Cell Lymphoma › California › Los Angeles
Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Los Angeles, CA
Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Los Angeles. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Nagre-recruitPhase 2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Nagre-recruitPhase 2
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Nagre-recruitPhase 3
- Cedars-Sinai Medical Center ( Site 0115), Los Angeles
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Nagre-recruitPhase 3
- David Geffen School of Medicine at UCLA, Los Angeles
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
- University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Nagre-recruitPhase 1/2
- Children's Hospital Los Angeles ( Site 1006), Los Angeles
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Nagre-recruitPhase 2
- Valkyrie Clinical Trials, Los Angeles
A Study of ARC-02 in B-cell NHL
Nagre-recruitPhase 1
- Start Cala, Los Angeles
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Nagre-recruitPhase 1/2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Nagre-recruitPhase 1
- Cedars-Sinai Medical Center, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Nagre-recruitPhase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA), Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Nagre-recruitPhase 1
- START Los Angele, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Nagre-recruitPhase 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Nagre-recruitPhase 1/2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Nagre-recruitPhase 2
- Cedars Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
Nagre-recruitPhase 1
- University of Southern California, Los Angeles
Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod
- New York City, NY21 pag-aaral
- Baldwin Park, CA19 pag-aaral
- Chicago, IL18 pag-aaral
- Houston, TX17 pag-aaral
- Boston, MA16 pag-aaral
- Milwaukee, WI16 pag-aaral
- Portland, OR15 pag-aaral
- Nashville, TN15 pag-aaral
- Philadelphia, PA15 pag-aaral
- Durham, NC14 pag-aaral
- Dallas, TX13 pag-aaral
- Seattle, WA12 pag-aaral
Iba pang pag-aaral sa Los Angeles
- Non-Small Cell Lung Cancer87 pag-aaral
- Kanser (lahat ng uri)73 pag-aaral
- Kanser sa Suso72 pag-aaral
- Kanser sa Prostate61 pag-aaral
- Colorectal Cancer59 pag-aaral
- Metastatic Cancer57 pag-aaral
- Kanser sa Ovary50 pag-aaral
- Kanser sa Baga45 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg42 pag-aaral
- Kanser sa Pancreas35 pag-aaral
- Kanser ng Endometrium34 pag-aaral
- Melanoma34 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.